The aggressive brain cancer quickly becomes treatment-resistant and the average survival remains at about 15 months.
In the first study to use CBD in an animal model of glioblastoma, researchers find inhaled CBD shrinks the size of the highly aggressive, lethal brain tumor glioblastoma by reducing the essential support of its microenvironment.